查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球藥品冷鏈市場：按初級包裝類型、二級包裝類型、使用類型和主要地區：過去趨勢（2019-2022年）以及估計和預測（2023-2035）
市場調查報告書
商品編碼
1398318

全球藥品冷鏈市場：按初級包裝類型、二級包裝類型、使用類型和主要地區：過去趨勢（2019-2022年）以及估計和預測（2023-2035）

Cold Chain Market for Pharmaceuticals: Distribution by Type of Primary Packaging, Type of Secondary Packaging, Type of Usability and Key Geographical Regions: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
出版日期: | 出版商: Roots Analysis | 英文 255 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

到 2023 年，全球冷鏈市場規模將達到 62 億美元，在預測期內（2023-2035 年）複合年增長率為 3.7%。

冷鏈代表了一個由精確校準的程序和設備組成的複雜系統，專為儲存和運輸溫度敏感物質而設計。 冷鏈依賴主動和被動熱包裝解決方案，包括冷鏈托運機、隔熱容器、冷媒和數據記錄器等監控設備。 廣泛應用於食品、乳製品、化學、醫藥領域，其主要目的是延長保存期限，保護生鮮食品、疫苗、藥品等易腐物品的品質和功效。 特別是，藥品冷鏈可滿足各種藥品（包括生物製劑、COVID-19 疫苗和器官移植）的嚴格溫度要求，確保其完整性和生存能力。 冷鏈監控的最新進展，特別是溫度感測器和即時追蹤設備的出現，透過允許在運輸過程中進行連續監控，大大提高了該過程的效率。

然而，挑戰仍然存在，特別是在藥品儲存和運輸過程中的包裝和溫度控制方面。 在一些地區，包裝和溫度控制不當導致很大一部分藥物失效。 設備故障或暴露在過熱環境等不可預見的事件可能會破壞冷鏈並造成損壞或污染的風險。 為了應對這些挑戰，行業利益相關者正在積極尋求混合解決方案。 這些創新方法將溫度數據記錄器整合到冷鏈貨櫃中，提高可視性並更有效地追蹤藥品運輸。 這種整合代表了傳統包裝解決方案的一種有前途的替代方案。 由於該行業的持續努力，考慮到持續的進步和強勁的成長軌跡，預計藥品冷鏈市場在預測期內將大幅擴張。

本報告對全球醫藥冷鏈市場進行了分析，包括市場的基本結構和最新情況、近期的重大資本交易和業務聯盟、推動和抑制市場的主要因素以及整體市場。規模、按細分市場和地區劃分的詳細趨勢以及主要公司的概況。

目錄

第一章前言

第二章分析方法

第 3 章經濟與其他專案特定考量

  • 分析概述
  • 市場動態

第 4 章執行摘要

第 5 章簡介

  • 分析概述
  • 冷鏈包裝概論
  • 冷鏈績效時間表
  • 製藥業的冷鏈解決方案
  • 冷鏈在製藥業的應用
  • 當前問題與未來前景

第六章整體市場狀況：冷鏈貨櫃/托運人提供者

  • 分析概述
  • 冷鏈貨櫃/托運商：整體市場情勢

第 7 章整體市場情勢：資料記錄器提供者

  • 分析概述
  • 數據記錄器提供者：整體市場情勢
  • 依成立年份分析
  • 依公司規模分析
  • 依總部所在地（地區）分析
  • 依總部地點（國家）分析
  • 依產品類型分析
  • 依資料傳輸方式分析
  • 按取得的資料類型進行分析
  • 依監測藥物類型分析
  • 依溫度範圍分析
  • 依產品類型和資料傳輸方式分析
  • 依照提供的產品類型和收集的資料類型進行分析

第 8 章競爭基準測試

  • 分析概述
  • 假設與研究方法
  • 冷鏈貨櫃/托運供應商的競爭基準
  • 結論

第九章公司簡介

  • 分析概述
  • Cold Chain Technologies
  • Cryopak
  • CSafe
  • EMBALL'ISO
  • Intelsius
  • Nordic Cold Chain Solutions
  • Peli BioThermal
  • SEE
  • SOFRIGAM
  • Sonoco Thermosafe
  • Tempack
  • Other Leading Players

第 10 章商業夥伴/合作

  • 分析概述
  • 業務夥伴關係/合作模式
  • 藥品冷鏈：業務夥伴關係/合作
  • 醫藥冷鏈：企業收購

第11章專利分析

  • 分析概述
  • 分析範圍/方法
  • 藥品冷鏈：專利分析
  • 醫藥冷鏈：專利基準分析
  • 專利評估分析

第 12 章監理建議與指引

  • 分析概述
  • 國際組織發布的監管指南
  • 國家主管機關發布的監理指南
  • 針對冷鏈每個步驟的建議
  • 監理機構比較分析

第 13 章未來趨勢與未來成長機會

  • 分析概述
  • 互聯冷鏈：關鍵工具與技術
  • 互聯冷鏈：未來成長機會
  • 即時監控：連網冷鏈解決方案的應用

第 14 章市場影響分析：驅動因素、限制、機會、挑戰

  • 分析概述
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場挑戰
  • 結論

第十五章藥品冷鏈市場

  • 分析概述
  • 假設與研究方法
  • 全球藥品冷鏈市場：過去趨勢（2019-2022）與預測（2023-2035）
  • 主要細分市場
  • 動態儀表板

第十六章藥品冷鏈市場：依初級包裝類型

  • 分析概述
  • 主要假設與研究方法
  • 小瓶：過去的趨勢（2019-2022 年）與預測（2023-2035 年）
  • 安瓿：過去的趨勢（2019-2022）與預測（2023-2035）
  • 預充式註射器：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 箱包：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 數據測量

第十七章藥品冷鏈市場：依二次包裝類型

  • 分析概述
  • 主要假設與研究方法
  • 冷箱：過去的趨勢（2019-2022）與預測（2023-2035）
  • 疫苗帶因者：過去的趨勢（2019-2022）與預測（2023-2035）
  • 保溫容器：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 數據測量

第 18 章藥品冷鏈市場：依使用類型劃分

  • 分析概述
  • 主要假設與研究方法
  • 可重複使用的貨櫃/托運商：過去的趨勢（2019-2022 年）和預測（2023-2035 年）
  • 一次性容器/托運商：過去趨勢（2019-2022 年）和預測（2023-2035 年）

第十九章醫藥冷鏈市場：依主要地區

  • 分析概述
  • 主要假設與研究方法
  • 北美：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 歐洲：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 亞太地區：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 中東與北美：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 拉丁美洲：過去趨勢（2019-2022 年）與預測（2023-2035 年）
  • 其他地區（世界各地）：過去趨勢（2019-2022 年）和預測（2023-2035 年）
  • 數據測量

第 20 章結論

第 21 章管理見解

  • 分析概述
  • EMBALL'ISO
  • Tower Cold Chain

第 22 章附錄 1：表格資料

第23章附錄2：公司與組織名單

簡介目錄
Product Code: RA100459

The global cold chain market is valued at USD 6.2 billion in 2023 growing at a CAGR of 3.7% during the forecast period 2023-2035.

The cold chain represents a sophisticated system of precisely coordinated steps and equipment designed for the storage and transportation of temperature-sensitive materials. It relies on both active and passive thermal packaging solutions, encompassing cold chain shippers, insulated containers, refrigerants, and monitoring devices like data loggers. Widely applied in food, dairy, chemical, and pharmaceutical sectors, its primary goal is to extend the shelf life of perishable items such as fresh produce, vaccines, and pharmaceuticals, safeguarding their quality and efficacy. Notably, the pharmaceutical cold chain caters to the stringent temperature requirements of various pharmaceutical products, including biologics, COVID vaccines, and organ transplants, ensuring their integrity and viability. Recent advancements in cold chain monitoring, particularly the emergence of temperature sensors and real-time tracking devices, have significantly enhanced the efficiency of this process by enabling continuous monitoring during shipment.

Nevertheless, challenges persist, especially concerning packaging and temperature control during pharmaceutical storage and transportation. Inadequate packaging and temperature control contribute to a substantial percentage of drugs losing their effectiveness in some regions. Unforeseen issues like equipment failures or exposure to excessive heat can disrupt the cold chain, posing risks of damage or contamination. To address these challenges, industry stakeholders are actively pursuing hybrid solutions. These innovative approaches integrate temperature data loggers into cold chain containers, enhancing visibility and enabling more efficient tracking of pharmaceutical shipments. This integration stands as a promising alternative to conventional packaging solutions. Considering the ongoing advancements and the robust growth trajectory of the pharmaceutical cold chain market, driven by continuous industry efforts, substantial expansion is anticipated in the forecasted period.

Key Market Segments

Type of Primary Packaging

  • Vials
  • Ampoules
  • Pre-filled Syringes
  • Bags

Type of Secondary Packaging

  • Cold Boxes
  • Vaccine Carriers
  • Insulated Containers

Type of Usability

  • Reusable
  • Single use

Key Geographical Regions:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America
  • Rest of the World

Research Coverage:

  • The report studies the cold chain market for pharmaceuticals based on type of primary packaging, type of secondary packaging, type of usability and key geographical regions
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.
  • The report forecasts the revenue of market segments with respect to six major regions
  • Detailed insights into the research approach adopted, encompassing methodologies, assumptions, and quality control measures employed to ensure precision and reliability of findings.
  • Historical trends, currency fluctuations, foreign exchange impacts, and measurements related to recession and inflation affecting the overall cold chain market for pharmaceuticals.
  • A high-level overview of current status and probable future evolution of the cold chain market in pharmaceuticals over the mid-to-long term.
  • Explaining cold chain packaging, its historical timeline, various packaging solutions, applications in the pharmaceutical industry, existing challenges, and future perspectives.
  • Comprehensive evaluation of 72 cold chain container/shipper providers based on parameters like establishment year, company size, headquarters location, product types, materials used, temperature storage, and services offered.
  • Detailed analysis of 70 data logger providers considering establishment year, company size, headquarters location, product types, data transmission modes, monitored parameters, and temperature ranges.
  • Comparison of key focus areas among cold chain container/shipper providers in North America, Europe, and Asia-Pacific, facilitating stakeholders to identify competitive advantages.
  • Detailed profiles of key cold chain container/shipper providers, highlighting company overview, product and service portfolios, recent developments, future outlook, and profiles of leading hybrid solution providers.
  • Examination of partnerships, collaborations, mergers, and acquisitions among stakeholders since 2019, including details on partnership types, applications, geography, and active players in the industry.
  • In-depth exploration of patents filed or granted since 2019, covering types, publication and application years, organizations, jurisdictions, focus areas, leading industry players, benchmarking, and valuation analysis.
  • Detailed discussion on regulatory guidelines issued by international and regional authorities, providing recommendations for different stages of the cold chain process along with a comparative analysis of regulatory bodies.
  • Examination of emerging trends, growth opportunities, technological advancements (AI, AR, IoT, etc.), real-time monitoring, integration methods, associated benefits, and cost efficiencies in the cold chain pharmaceutical industry.
  • Analysis of factors influencing the growth of the cold chain market for pharmaceuticals, including drivers, restraints, opportunities, and challenges.

Key Benefits of Buying this Report:

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the cold chain market for pharmaceuticals, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Cold Chain Technologies
  • Cryopak
  • CSafe

EMBALL'ISO

  • Intelsius
  • Nordic Cold Chain Solutions
  • Peli BioThermal

SEE

SOFRIGAM

  • Sonoco Thermosafe
  • Tempack

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Cold Chain Market for Pharmaceuticals
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Introduction to Cold Chain Packaging
  • 5.3. Historical Timeline of Cold Chain
  • 5.4. Cold Chain Solutions for Pharmaceutical Industry
    • 5.4.1. Cold Chain Packaging Solutions: Containers and Shippers
      • 5.4.1.1. Active Cold Chain Packaging Solutions
      • 5.4.1.2. Passive Cold Chain Packaging Solutions
      • 5.4.1.3. Insulated Cold Chain Packaging Solutions
    • 5.4.2. Cold Chain Monitoring Solutions: Data Loggers
      • 5.4.2.1. Data Loggers
      • 5.4.2.2. Indicators
  • 5.5. Applications of Cold Chain in Pharmaceutical Industry
  • 5.6. Current Challenges and Future Perspectives

6. OVERALL MARKET LANDSCAPE: COLD CHAIN CONTAINER / SHIPPER PROVIDERS

  • 6.1. Chapter Overview
  • 6.2. Cold Chain Container / Shipper Providers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Type of Cold Chain Solution
    • 6.2.6. Analysis by Type of Product Offered
    • 6.2.7. Analysis by Type of Product Material
    • 6.2.8. Analysis by Type of Product Packaged
    • 6.2.9. Analysis by Storage Temperature
    • 6.2.10. Analysis by Type of Service Offered
    • 6.2.11. Analysis by Company Size and Type of Service Offered

7. OVERALL MARKET LANDSCAPE: DATA LOGGER PROVIDERS

  • 7.1. Chapter Overview
  • 7.2. Data Logger Providers: Overall Market Landscape
  • 7.3. Analysis by Year of Establishment
  • 7.4. Analysis by Company Size
  • 7.5. Analysis by Location of Headquarters (Region)
  • 7.6. Analysis by Location of Headquarters (Country)
  • 7.7. Analysis by Type of Product Offered
  • 7.8. Analysis by Mode of Data Transmission
  • 7.9. Analysis by Type of Data Captured
  • 7.10. Analysis by Type of Pharmaceutical Monitored
  • 7.11. Analysis by Temperature Range
  • 7.12. Analysis by Type of Product Offered and Mode of Data Transmission
  • 7.13. Analysis by Type of Product Offered and Type of Data Captured

8. COMPETITIVE BENCHMARKING

  • 8.1. Chapter Overview
  • 8.2. Assumptions and Methodology
  • 8.3. Competitive Benchmarking of Cold Chain Container / Shipper Providers
    • 8.3.1. Competitive Benchmarking: Players based in North America (Peer Group I)
    • 8.3.2. Competitive Benchmarking: Players based in Europe (Peer Group II)
    • 8.3.3. Competitive Benchmarking: Large Players based in Asia-Pacific and RoW (Peer Group III)
  • 8.4. Concluding Remarks

9. COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Cold Chain Technologies
    • 9.2.1. Company Overview
    • 9.2.2. Product Portfolio
    • 9.2.3. Service Portfolio
    • 9.2.4. Recent Developments and Future Outlook
  • 9.3. Cryopak
    • 9.3.1. Company Overview
    • 9.3.2. Product Portfolio
    • 9.3.3. Service Portfolio
    • 9.3.4. Recent Developments and Future Outlook
  • 9.4. CSafe
    • 9.4.1. Company Overview
    • 9.4.2. Product Portfolio
    • 9.4.3. Service Portfolio
    • 9.4.4. Recent Developments and Future Outlook
  • 9.5. EMBALL'ISO
    • 9.5.1. Company Overview
    • 9.5.2. Product Portfolio
    • 9.5.3. Service Portfolio
    • 9.5.4. Recent Developments and Future Outlook
  • 9.6. Intelsius
    • 9.6.1. Company Overview
    • 9.6.2. Product Portfolio
    • 9.6.3. Service Portfolio
    • 9.6.4. Recent Developments and Future Outlook
  • 9.7. Nordic Cold Chain Solutions
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Service Portfolio
    • 9.7.4. Recent Developments and Future Outlook
  • 9.8. Peli BioThermal
    • 9.8.1. Company Overview
    • 9.8.2. Product Portfolio
    • 9.8.3. Service Portfolio
    • 9.8.4. Recent Developments and Future Outlook
  • 9.9. SEE
    • 9.9.1. Company Overview
    • 9.9.2. Product Portfolio
    • 9.9.3. Service Portfolio
    • 9.9.4. Recent Developments and Future Outlook
  • 9.10. SOFRIGAM
    • 9.10.1. Company Overview
    • 9.10.2. Product Portfolio
    • 9.10.3. Service Portfolio
    • 9.10.4. Recent Developments and Future Outlook
  • 9.11. Sonoco Thermosafe
    • 9.11.1. Company Overview
    • 9.11.2. Product Portfolio
    • 9.11.3. Service Portfolio
    • 9.11.4. Recent Developments and Future Outlook
  • 9.12. Tempack
    • 9.12.1. Company Overview
    • 9.12.2. Product Portfolio
    • 9.12.3. Service Portfolio
    • 9.12.4. Recent Developments and Future Outlook
  • 9.13. Other Leading Players
    • 9.13.1. Almac
    • 9.13.2. B Medical Systems
    • 9.13.3. BioLife Solutions
    • 9.13.4. CRS Mobile Cold Storage
    • 9.13.5. Desert Valley Tech
    • 9.13.6. Dubai Instruments
    • 9.13.7. Envirotainer
    • 9.13.8. Global Cold Chain Solutions (Headquartered in Australia)
    • 9.13.9. Global Cold Chain Solutions (Headquartered in Singapore)
    • 9.13.10. Klinge
    • 9.13.11. Krautz-temax
    • 9.13.12. Meds2go
    • 9.13.13. phasetwo
    • 9.13.14. Polar Tech Industries
    • 9.13.15. Skycell
    • 9.13.16. UPS Healthcare

10. PARTNERSHIPS AND COLLABORATIONS

  • 10.1. Chapter Overview
  • 10.2. Partnership Models
  • 10.3. Cold Chain for Pharmaceuticals: Partnerships and Collaborations
    • 10.3.1. Analysis by Year of Partnership
    • 10.3.2. Analysis by Type of Partnership
    • 10.3.3. Analysis by Year and Type of Partnership
    • 10.3.4. Analysis by Application Area
    • 10.3.5. Analysis by Type of Product / Technology
    • 10.3.6. Analysis by Geography
      • 10.3.6.1. Local and International Agreements
      • 10.3.6.2. Intercontinental and Intracontinental Agreements
    • 10.3.7 Most Active Players: Analysis by Number of Partnerships
  • 10.4. Cold Chain for Pharmaceuticals: Acquisitions
    • 10.4.1. Analysis by Year of Acquisition
    • 10.4.2. Analysis by Type of Acquisition
    • 10.4.2. Analysis by Year and Type of Acquisition
    • 10.4.3. Analysis by Application Area
    • 10.4.4. Analysis by Type of Product / Technology
    • 10.4.5. Analysis by Geography
      • 10.4.5.1. Local and International Agreements
      • 10.4.5.2. Intercontinental and Intracontinental Agreements
    • 10.4.6. Ownership Change Matrix
    • 10.4.7. Analysis by Key Value Drivers

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Cold Chain for Pharmaceuticals: Patent Analysis
    • 11.3.1. Analysis by Type of Patent
    • 11.3.2. Analysis by Publication Year
    • 11.3.3. Analysis by Type of Patent and Publication Year
    • 11.3.4. Analysis by Application Year
    • 11.3.5. Analysis by Type of Organization
    • 11.3.6. Analysis by Patent Jurisdiction
    • 11.3.7. Analysis by CPC Symbols
    • 11.3.8. Analysis by Emerging Focus Area
    • 11.3.9. Leading Industry Players: Analysis by Number of Patents
  • 11.4. Cold Chain for Pharmaceuticals: Patent Benchmarking Analysis
    • 11.4.1. Analysis by Patent Characteristics
      • 11.4.1.1. Cold Chain Technologies and Ember LifeSciences
      • 11.4.1.2. Other Leading Patent Assignees
  • 11.5. Patent Valuation Analysis

12. REGULATORY RECOMMENDATIONS AND GUIDELINES

  • 12.1. Chapter Overview
  • 12.2. Regulatory Guidelines Issued by International Authorities
    • 12.2.1. World Health Organization (WHO)
    • 12.2.2. International Air Transport Association (IATA)
    • 12.2.3. International Safe Transit Association (ISTA)
  • 12.3. Regulatory Guidelines Issued by Regional Authorities
    • 12.3.1. Regulatory Guidelines for Cold Chain Management in the US
      • 12.3.1.1. United States Food and Drug Administration (USFDA)
    • 12.3.2. United States Pharmacopeia (USP)
    • 12.3.3. Regulatory Guidelines for Cold Chain Management in Canada
      • 12.3.3.1. Health Canada
    • 12.3.4. Regulatory Guidelines for Cold Chain Management in Europe
      • 12.3.4.1. European Medicine Agency
  • 12.4. Recommendations for Different Steps of Cold Chain
  • 12.5. Comparative Analysis of Regulatory Authorities

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

  • 13.1. Chapter Overview
  • 13.2. Connected Cold Chain: Key Tools and Technologies
    • 13.2.1. Artificial Intelligence
    • 13.2.2. Augmented Reality
    • 13.2.3. Automation and Robotics
    • 13.2.4. Big Data Analytics
    • 13.2.5. Block Chain Technology
    • 13.2.6. Cloud Computing
    • 13.2.7. Internet of Things
    • 13.2.8. Radio Frequency Identification (RFID) Tags
  • 13.3. Connected Cold Chain: Future Growth Opportunities
  • 13.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
    • 13.4.1 Methods for Integration of Real-Time Monitoring in Cold Chain
      • 13.4.1.1. RFID Based Real-Time Monitoring
      • 13.4.1.2. Blockchain And IoT Based Real-Time Monitoring
    • 13.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
    • 13.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 14.1. Chapter Overview
  • 14.2. Market Drivers
  • 14.3. Market Restraints
  • 14.4. Market Opportunities
  • 14.5. Market Challenges
  • 14.6. Conclusion

15. COLD CHAIN MARKET FOR PHARMACEUTICALS

  • 15.1. Chapter Overview
  • 15.2. Assumptions and Methodology
  • 15.3. Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 15.3.1. Scenario Analysis
  • 15.4. Key Market Segmentations
  • 15.5. Dynamic Dashboard

16. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF PRIMARY PACKAGING

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Vials: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Ampoules: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.5. Pre-filled Syringes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.6. Bags: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 16.7. Data Triangulation
    • 16.7.1. Insights from Primary Research
    • 16.7.2. Insights from Secondary Research
    • 16.7.3. Insights from In-house Repository

17. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF SECONDARY PACKAGING

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Cold Boxes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Vaccine Carriers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Insulated Containers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 17.6. Data Triangulation
    • 17.6.1. Insights from Primary Research
    • 17.6.2. Insights from Secondary Research
    • 17.7.3. Insights from In-house Repository

18. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF USABILITY

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Reusable Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 18.4. Single-use Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

19. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY KEY GEOGRAPHICAL REGIONS

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.4. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.5. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.6. Middle East and North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.7. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035
  • 19.8. Rest of the World: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.9. Data Triangulation
    • 19.9.1. Insights from Primary Research
    • 19.9.2. Insights from Secondary Research
    • 19.9.3. Insights from In-house Repository

20. CONCLUSION

21. EXECUTIVE INSIGHTS

  • 21.1. Chapter Overview
  • 21.2. EMBALL'ISO
    • 21.2.1. Company Snapshot
    • 21.2.2. Interview Transcript
  • 21.3. Tower Cold Chain
    • 21.3.1. Company Snapshot
    • 21.3.2. Interview Transcript

22. APPENDIX 1: TABULATED DATA

23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS